MDXG

MIMEDX GROUP, INC. MDXG

NasdaqSmall CapHealthcare

13F Pro quality score

Rank #1,989 of 2,925

Why it scores 43Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.

Revenue

$64.36M

Quarter to Jun 30

Net income

$-14.84M

Quarter to Jun 30

Operating margin

-28.7%

Quarter to Jun 30

Top Institutional Holders

as of Q2 2026
$430.83M total
Essex Woodlands Management, Inc.
$108.55M0.0%
BlackRock, Inc.
$46.79M+2.0%
Trigran Investments, Inc.
$27.62M0.0%
STATE STREET CORP
$21.48M+10.3%
VANGUARD CAPITAL MANAGEMENT LLC
$19.97M+0.4%
Nantahala Capital Management, LLC
$18.36M+40.3%
PARADIGM CAPITAL MANAGEMENT INC/NY
$15.68M+19.4%
GEODE CAPITAL MANAGEMENT, LLC
$12.11M+9.1%
GOLDMAN SACHS GROUP INC
$10.26M+124.8%
AQR CAPITAL MANAGEMENT LLC
$9.50M+170.3%
RENAISSANCE TECHNOLOGIES LLC
$9.41M-19.1%
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC.
$7.92M+1.9%
DIMENSIONAL FUND ADVISORS LP
$7.49M-27.8%
CANNELL CAPITAL LLC
$7.20M+24.9%
NORTHERN TRUST CORP
$5.07M+28.8%
VANGUARD PORTFOLIO MANAGEMENT LLC
$4.97M+16.7%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
$4.88M+63.3%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
$4.78M-10.0%
Meros Investment Management, LP
$4.32M+2.6%
MORGAN STANLEY
$4.02M+28.4%
Qube Research & Technologies Ltd
$3.81M-40.0%
CITADEL ADVISORS LLC
$3.18M+6.4%
JANE STREET GROUP, LLC
$3.05M+50.8%
VANGUARD FIDUCIARY TRUST CO
$2.98M-5.8%
KENNEDY CAPITAL MANAGEMENT LLC
$2.96MNew
See all 228 institutional holders →
Reading the latest SEC filing…

Key Metrics

Revenue

Q2 2026
EDGAR

Net Income

Q2 2026
EDGAR

EPS (Diluted)

Q2 2026
EDGAR

Operating Margin

Q2 2026
EDGAR

ROIC

Q2 2026
EDGAR

Debt/Equity

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/MDXG

Earnings Per Share

13fpro.ai/company/MDXG

Loading ratio trend…

MDXG key financials by period

Reported revenue, net income and operating margin by fiscal year, from MIMEDX GROUP, INC.'s annual filings on SEC EDGAR.

MIMEDX GROUP, INC. reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2025$418.6M$48.6M15.3%
FY 2024$348.9M$42.4M16.9%
FY 2023$321.5M$58.2M11.6%
FY 2022$267.8M$-30.2M-5.5%
FY 2021$242.0M$-10.3M-2.9%
FY 2020$248.2M$-49.3M-18.3%
Source: MDXG filings on SEC EDGAR →

Companies similar to MDXG

Ranked by quality-factor profile and overlapping institutional ownership, from the latest 13F filings and SEC financials.

MDXG insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About MIMEDX GROUP, INC. (MDXG): stock profile, AI score and financials

MIMEDX GROUP, INC. (MDXG) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores MDXG at 42.9/100 on a composite quality score built from its SEC filings, placing it at rank #1,989 of 2,925 stocks — the bottom half of the AI-ranked universe. MDXG scores in the top quartile across earnings quality (97.6). Areas of concern include profitability (28.2) and revenue growth (31.8), which score below median versus the broader universe. Shareholder dilution risk is elevated at 27.4/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), MIMEDX GROUP, INC. reports quarterly revenue of $64.4M, net income of $-14.8M, an operating margin of -28.7%. MDXG trades on the Nasdaq exchange and files with the SEC under CIK 1376339. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate MDXG daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for MIMEDX GROUP, INC. directly from SEC EDGAR.

SEC EDGAR: CIK 1376339 →